HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Business Round-Up: Stada Enters Germany Top-5, Dr Wolff Takes Vagisan To Poland, Fidia And Sanova Strike Nasal Spray Deals

Executive Summary

Acquiring six brands from GSK has propelled Stada into Germany's OTC top-5; Dr. Wolff has secured distribution for its Vagisan women's health brand in Poland; and Sanova and Fidia have added innovative nasal sprays to their respective portfolios.

You may also be interested in...



German Immunity And Cognitive Health Supplement Launches From Stada, Hermes, Dr Loges, Dr Theiss

Germany’s consumer healthcare players are on trend with recent launches, which include a chewable version of Stada’s Cetebe vitamin C brand, a slow-release addition to Hermes’ Bioelectra Magnesium range, a melatonin-plus-tryptophan supplement from Dr Loges and an immunity spray from Dr Theiss.

EU Business Round-Up: Galderma Divests To Dallman’s, Oysershell names CEO, Ceres Acquires

Latest business news in the EU: Galderma offloads German Bübchen brand to Dallman's; Belgium's Oystershell names experienced CEO; Ceres Pharma snaps up Romania's Viva.

Stada Grabs GSK Brands In Key EU Markets

Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales in excess of €100m.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150087

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel